Wealth Management Partners, LLC Summit Therapeutics Inc. Transaction History
Wealth Management Partners, LLC
- $212 Million
- Q1 2025
A detailed history of Wealth Management Partners, LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Wealth Management Partners, LLC holds 96,283 shares of SMMT stock, worth $2.61 Million. This represents 0.92% of its overall portfolio holdings.
Number of Shares
96,283
Previous 97,383
1.13%
Holding current value
$2.61 Million
Previous $1.74 Million
12.54%
% of portfolio
0.92%
Previous 0.76%
Shares
6 transactions
Others Institutions Holding SMMT
# of Institutions
230Shares Held
83.1MCall Options Held
1.66MPut Options Held
2.56M-
Baker Bros. Advisors LP New York, NY24.4MShares$663 Million4.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$317 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$214 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$178 Million0.01% of portfolio
-
State Street Corp Boston, MA5.6MShares$152 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $5.46B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...